b-Fast.ai
About
What does b-Fast.ai do?
b-Fast.ai has developed a novel and patented method for the rapid identification of bacterial pathogens and their susceptibility to antibiotics. Their technology aims to deliver results within 45 minutes, significantly reducing the time required for clinical decision-making in infectious disease treatment.
Where is b-Fast.ai headquartered?
b-Fast.ai is headquartered in Tel Aviv, Israel.
When was b-Fast.ai founded?
b-Fast.ai was founded in 2022.
What industry does b-Fast.ai operate in?
b-Fast.ai operates in Healthcare, HealthTech, MedTech, Biotech, Drug Discovery, Clinical Trials.
What is b-Fast.ai's current status?
b-Fast.ai's current operating status is: Inactive.
AI-powered platform for healthcare providers to manage patient WhatsApp messages efficiently.
AI-powered platform for personalized weight management and health coaching.
Clinical Trial Discovery by ENSCORE.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Medbytes provides doctors with a personalized platform for high-impact medical research and news in their specialty.
SYLARIS™ offers premium wearable wellness patches and clinical-grade skincare designed for effortless, intentional, and beautifully designed self-care rituals.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Purpose-built WordPress plugins for healthcare and the agencies that serve them.
An entrant is a company tagged HealthTech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 6 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.